ATE230270T1 - Puderpräparat zur heilung verletzter haut - Google Patents

Puderpräparat zur heilung verletzter haut

Info

Publication number
ATE230270T1
ATE230270T1 AT95108920T AT95108920T ATE230270T1 AT E230270 T1 ATE230270 T1 AT E230270T1 AT 95108920 T AT95108920 T AT 95108920T AT 95108920 T AT95108920 T AT 95108920T AT E230270 T1 ATE230270 T1 AT E230270T1
Authority
AT
Austria
Prior art keywords
powder preparation
salts
injured skin
healing
healing injured
Prior art date
Application number
AT95108920T
Other languages
English (en)
Inventor
Toshio Inagi
Saibi Suehiro
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE230270T1 publication Critical patent/ATE230270T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT95108920T 1994-06-27 1995-06-09 Puderpräparat zur heilung verletzter haut ATE230270T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14439394A JP3583166B2 (ja) 1994-06-27 1994-06-27 損傷皮膚修復用粉末製剤

Publications (1)

Publication Number Publication Date
ATE230270T1 true ATE230270T1 (de) 2003-01-15

Family

ID=15361113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95108920T ATE230270T1 (de) 1994-06-27 1995-06-09 Puderpräparat zur heilung verletzter haut

Country Status (12)

Country Link
US (1) US5618799A (de)
EP (1) EP0689841B1 (de)
JP (1) JP3583166B2 (de)
KR (1) KR100370313B1 (de)
CN (1) CN1059088C (de)
AT (1) ATE230270T1 (de)
CA (1) CA2150888A1 (de)
DE (1) DE69529249T2 (de)
DK (1) DK0689841T3 (de)
ES (1) ES2189811T3 (de)
SI (1) SI0689841T1 (de)
TW (1) TW336173B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU722246B2 (en) * 1995-06-07 2000-07-27 Johnson & Johnson Consumer Products, Inc. Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same
US6562885B1 (en) 1998-03-19 2003-05-13 Battelle Memorial Institute Composition for deactivating chemically and biologically active agents and method of making the same
WO1999065538A1 (en) 1998-06-19 1999-12-23 Oxibio, Inc. Medical device having anti-infective and contraceptive properties
US6414223B1 (en) * 1998-08-03 2002-07-02 Cargill, Incorporated Plants, seeds and oils having an elevated total monounsaturated fatty acid content
CA2355241A1 (en) 1999-02-26 2000-08-31 Warner-Lambert Company Bioadhesive antibacterial wound healing composition
JP2001122790A (ja) * 1999-10-22 2001-05-08 Mikasa Seiyaku Co Ltd 安定な褥瘡・皮膚潰瘍および創傷治療用製剤
US8323693B2 (en) 2002-03-14 2012-12-04 Medrx Co., Ltd. External preparation for wounds
WO2004011032A1 (ja) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. 外用剤
US20060034945A1 (en) * 2002-11-11 2006-02-16 Kowa Co., Ltd Composition for restoring damaged skin
US20040101507A1 (en) * 2002-11-27 2004-05-27 Janco Predovan Skin cream
AU2003293818A1 (en) * 2002-12-19 2004-07-14 Gunther Beisel Method for producing agents which are to be administered orally and corresponding compositions using polymers and coatings thereof consisting of hydrophilic liquids
RU2245723C1 (ru) * 2003-07-24 2005-02-10 Вилесов Александр Дмитриевич Средство и способ лечения гнойно-воспалительных заболеваний мягких тканей
JP4575881B2 (ja) * 2003-09-22 2010-11-04 興和株式会社 損傷皮膚修復用貼付剤
US7673841B2 (en) 2004-03-25 2010-03-09 Cooper Technologies Company Hangar bar for recessed luminaires with integral nail
JP4575706B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
JP4575705B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
US7334538B1 (en) * 2004-07-27 2008-02-26 Aquascience Research Group, Inc. Topical medicants for aquatic animals
CN1279917C (zh) * 2004-09-09 2006-10-18 吕益明 一种创伤药及其制备方法和使用方法
WO2006118137A1 (ja) 2005-04-26 2006-11-09 Dainippon Sumitomo Pharma Co., Ltd. ビグアナイド系薬物を含有する粒状製剤
NZ542258A (en) * 2005-09-06 2010-05-28 Comvita New Zealand Ltd A medical composition comprising honey or sugar syrup and a viscosity increasing agent for use on wounds
WO2007049952A1 (en) * 2005-10-28 2007-05-03 Nature Products Holding B.V. Polymeric compound, method of preparing a polymeric compound, use of a polymeric compound
EP2095812A4 (de) 2006-10-25 2011-07-13 Dainippon Sumitomo Pharma Co Nicht zusammenbackende granulatförmige zubereitung
JP5289975B2 (ja) * 2006-12-07 2013-09-11 第一三共株式会社 マンニトール又は乳糖を含有する固形製剤
BRPI0719393B8 (pt) 2006-12-07 2021-05-25 Daiichi Sankyo Co Ltd composição farmacêutica
US20100280064A1 (en) * 2006-12-07 2010-11-04 Tomoyuki Watanabe Pharmaceutical composition having improved storage stability
US20090291138A1 (en) * 2006-12-07 2009-11-26 Daiichi Sankyo Company, Limited Film-coated preparation having improved stability
WO2010033258A1 (en) * 2008-09-22 2010-03-25 Triosyn Holding Inc. A novel lodinated resin manufacturing process and product
CN101654499B (zh) * 2009-09-02 2011-08-31 陈煜� 天然高分子或其水溶性衍生物的两亲性接枝共聚物与纳米碘复合物及其制备方法
CN102846776B (zh) * 2012-09-28 2015-02-11 刘艳 一种由桃树末制成的药剂
US20170333472A1 (en) * 2014-12-30 2017-11-23 3M Innovative Properties Company Bactericidal composition
MX2017009450A (es) * 2015-01-20 2018-01-18 Veloce Biopharma Llc Composicion yodofora novedosa y metodos de uso.
CA3219774A1 (en) * 2021-05-18 2022-11-24 Povinez Llc Nasal antiseptic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353297A1 (fr) * 1976-01-26 1977-12-30 Tissier Gerard Nouveaux complexes neutres et insolubles de la polyvinylpolypyrrolidone et des halogenes, leurs procedes d'obtention et leurs applications
US4094967A (en) * 1976-10-22 1978-06-13 Allor Foundation Iodine-polyvinylpyrrolidone solid product and method of preparation
AU536885B2 (en) * 1979-04-18 1984-05-31 R. A. Knutson Wound and burn dressing
DE3312431A1 (de) * 1983-04-07 1984-10-11 B. Braun Melsungen Ag, 3508 Melsungen Pvp-iod-wundpuder mit synergistisch wirkender pudergrundlage
NL8500774A (nl) * 1985-03-18 1986-10-16 Dagra Nv Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
CA1287584C (en) * 1986-09-02 1991-08-13 Seiichi Komori Wound-healing preparations
GB8622012D0 (en) * 1986-09-12 1986-10-22 Euro Celtique Sa Solid iodophor composition
CH678697A5 (de) * 1989-04-03 1991-10-31 Warner Lambert Co
US4877927A (en) * 1989-04-06 1989-10-31 Hamlin Incorporated Extended dwell shock sensing device

Also Published As

Publication number Publication date
KR100370313B1 (ko) 2003-03-19
TW336173B (en) 1998-07-11
JPH0812582A (ja) 1996-01-16
DK0689841T3 (da) 2003-02-24
US5618799A (en) 1997-04-08
JP3583166B2 (ja) 2004-10-27
CN1124143A (zh) 1996-06-12
KR960000214A (ko) 1996-01-25
EP0689841B1 (de) 2003-01-02
ES2189811T3 (es) 2003-07-16
DE69529249T2 (de) 2003-08-07
CA2150888A1 (en) 1995-12-28
CN1059088C (zh) 2000-12-06
SI0689841T1 (en) 2003-04-30
EP0689841A1 (de) 1996-01-03
DE69529249D1 (de) 2003-02-06

Similar Documents

Publication Publication Date Title
ATE230270T1 (de) Puderpräparat zur heilung verletzter haut
EP0366101A3 (de) Verfahren zum Ueberdecken des Geschmacks von Ibuprofon
CA2356310A1 (en) External preparations containing a basic drug
SE8803321D0 (sv) Fordrojd och styrd frigoring av vattenolosliga polypeptider
SE9101853D0 (sv) Improved tissue ashesive
TW229217B (de)
MY113488A (en) Compounds with growth hormone releasing properties
AP2003002936A0 (en) Crystalline forms of 'R-(R*,R*)!-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methy lethyl)-3-phenyl-4- ?phenylamino) carbonyl!-1H-pyrrole-1-heptano IC acid calcium salt (2:1) (atorvastatin).
AU6949594A (en) Substituted oxazolyl compounds for the treatment of inflammation
CA2174072A1 (en) Hydrogel-forming, self-solvating absorbable polyester block copolymers, and methods for use thereof
EP0992501A3 (de) Pyridoncarbonsäurederivate als antibakterielle Wirkstoffe
BR0107942A (pt) Polìmeros de proteìna de liberação lenta
EP0796623A3 (de) Pharmazeutisches Präparat zur Behandlung von Blutgerinnungs-störungen
DK0642301T3 (da) Farmaceutisk acceptable fikserede, tørrede humane blodplader
FR2670676B1 (fr) Systeme de manutention de matieres residuelles, notamment medicales.
CA2395846A1 (en) Diazepan derivatives or salts thereof
EP0369262A3 (de) Pyrrol-Derivate
ATE226450T1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
BR9714179A (pt) Composição absorvìvel contendo bactérias propiÈnicas capazes de liberar monóxido de nitrogênio no tubo digestivo humano ou animal
DK0605381T3 (da) Polymerforbindelse, især til medicinske anvendelser
ZA979411B (en) The use of lithium compounds for combatting human papilloma virus infections.
AU2253197A (en) Novel substituted N-Methyl-N-(4-(4-(1H-benzimidazol- 2-yl){1,4}diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
EP0855191A3 (de) Methoden zur Behandlung von Oberflächenwunden mit Cyanoacrylatester-Zusammensetzungen, die antimikrobielle Verbindungen enthalten
EP0337643A3 (de) 6-Substituierte Acrylamido-Penizillansäure-Derivate, Herstellung und Verwendung
CA2057456A1 (en) Anti depression pharmaceutical

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0689841

Country of ref document: EP

REN Ceased due to non-payment of the annual fee